Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Other Operating Expenses: 2019-2020

Historic Other Operating Expenses for Outlook Therapeutics (OTLK) over the last 2 years, with Sep 2020 value amounting to $527,624.

  • Outlook Therapeutics' Other Operating Expenses rose 104.80% to $104,296 in Q2 2020 from the same period last year, while for Jun 2020 it was $8.9 million, marking a year-over-year change of. This contributed to the annual value of $527,624 for FY2020, which is 95.32% down from last year.
  • Outlook Therapeutics' Other Operating Expenses amounted to $527,624 in FY2020, which was down 95.32% from $11.3 million recorded in FY2019.
  • Outlook Therapeutics' 5-year Other Operating Expenses high stood at $11.3 million for FY2019, and its period low was $527,624 during FY2020.
  • Over the past 2 years, Outlook Therapeutics' median Other Operating Expenses value was $5.9 million (recorded in 2019), while the average stood at $5.9 million.
  • Data for Outlook Therapeutics' Other Operating Expenses shows a maximum YoY crashed of 95.32% (in 2020) over the last 5 years.
  • Yearly analysis of 2 years shows Outlook Therapeutics' Other Operating Expenses stood at $11.3 million in 2019, then tumbled by 95.32% to $527,624 in 2020.